Alzheimer's disease (AD)
Showing 1 - 25 of >10,000
Mild Cognitive Impairment, Alzheimer Trial in Atlanta (Citicoline Supplement, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Citicoline Supplement
- Placebo
-
Atlanta, Georgia
- +1 more
Sep 1, 2023
Alzheimer, Benson's Disease Trial in Tours ([18F]T807 PET)
Completed
- Alzheimer Disease
- Benson's Disease
- [18F]T807 PET
-
Tours, FranceUniversity Hospital of Tours
Sep 8, 2022
Alzheimer's Disease (AD) Trial (SHR-1707 injection)
Not yet recruiting
- Alzheimer's Disease (AD)
- SHR-1707 injection
- (no location specified)
Nov 2, 2023
Alzheimer Trial in Maastricht, Amsterdam (Tear Fluid collection (Schirmer's strip), Retinal imaging)
Recruiting
- Alzheimer Disease
- Tear Fluid collection (Schirmer's strip)
- Retinal imaging
-
Maastricht, Limburg, Netherlands
- +1 more
Dec 16, 2022
Mild Alzheimer's Disease Trial (active rTMS, sham rTMS)
Not yet recruiting
- Mild Alzheimer's Disease
- active rTMS
- sham rTMS
- (no location specified)
May 14, 2023
Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
Recruiting
- Alzheimer's Disease
-
Beijing, Beijing, ChinaXuanwu Hospital of Capital Medical University
Nov 15, 2022
Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Alzheimer Dementia
- CpG1018
- Placebo
- (no location specified)
Jan 3, 2023
Alzheimer Trial in Beijing (XTR006)
Recruiting
- Alzheimer Disease
-
Beijing, Beijing Shi, ChinaChinese PLA General Hospital
Nov 21, 2023
Suspected Typical Alzheimer's Disease (AD), Suspected Atypical Alzheimer's Disease (AD) Trial (Face-to-face evaluation (FF),
Recruiting
- Suspected Typical Alzheimer's Disease (AD)
- Suspected Atypical Alzheimer's Disease (AD)
- Face-to-face evaluation (FF)
- TeleNP evaluation
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus (CU-AMC)
Sep 2, 2022
Alzheimer Trial in Saint-Étienne (Cognitive tests)
Not yet recruiting
- Alzheimer Disease
- Cognitive tests
-
Saint-Étienne, FranceCHU de Saint-Etienne
Oct 23, 2023
Mild Cognitive Impairment, Alzheimer, Amnestic Mild Cognitive Disorder Trial in Ann Arbor (Diagnostic Disclosure Protocol,
Enrolling by invitation
- Mild Cognitive Impairment
- +2 more
- Diagnostic Disclosure Protocol
- Biomarker Disclosure Protocol
-
Ann Arbor, MichiganThe University of Michigan
Jan 20, 2023
Alzheimer, Mild Cognitive Impairment, Neuro-Degenerative Disease Trial in Tijuana (SNK01)
Recruiting
- Alzheimer Disease
- +2 more
- SNK01
-
Tijuana, Baja California, MexicoHospital Angeles Tijuana
Sep 27, 2022
Alzheimer, Parkinson Disease Trial in Antalya, Istanbul (Metabolic Cofactor Supplementation, Sorbitol)
Completed
- Alzheimer Disease
- Parkinson Disease
- Metabolic Cofactor Supplementation
- Sorbitol
-
Antalya, Turkey
- +1 more
Aug 5, 2022
Alzheimer's Disease Trial in Israel, United Kingdom (IBC-Ab002, Placebo)
Not yet recruiting
- Alzheimer's Disease
- IBC-Ab002
- Placebo
-
Haifa, Israel
- +5 more
Sep 20, 2022
Alzheimer Trial in Saint Paul (Intermittent theta burst stimulation)
Recruiting
- Alzheimer Disease
- Intermittent theta burst stimulation
-
Saint Paul, MinnesotaHealthPartners Neuroscience Center
Sep 27, 2022
Alzheimer's Disease Trial in Heidelberg, Shepparton, West Perth (SLS-005, Placebo)
Not yet recruiting
- Alzheimer's Disease
- SLS-005
- Placebo
-
Heidelberg, Victoria, Australia
- +2 more
Dec 23, 2022
Epilepsy Trial in France (profile of CSF biomarkers of AD)
Active, not recruiting
- Epilepsy
- profile of CSF biomarkers of AD
-
Bron, France
- +3 more
Mar 14, 2022
Alzheimer's Disease and Related Dementias Family Caregivers Trial in Phoenix (Music Listening Control (MLC), Heart Focused
Recruiting
- Alzheimer's Disease and Related Dementias Family Caregivers
- Music Listening Control (MLC)
- Heart Focused Breathing
-
Phoenix, ArizonaArizona State University
May 17, 2022
Neurocognitive Disorders (MG)
Recruiting
- Alzheimer Disease
- +2 more
- Identification of Graphic Markers
-
Montréal, Quebec, CanadaCRIUGM
Sep 8, 2022
Mild Cognitive Impairment, Mild Dementia, Alzheimer's Disease Trial in United States (SAGE-718, SAGE-718-matching Placebo)
Recruiting
- Mild Cognitive Impairment
- +2 more
- SAGE-718
- SAGE-718-matching Placebo
-
Redlands, California
- +3 more
Jan 13, 2023
Dementia, Cognitive Dysfunction, Alzheimer Trial in Madison (Relational Research Recruitment and Engagement Intervention)
Not yet recruiting
- Dementia
- +4 more
- Relational Research Recruitment and Engagement Intervention
-
Madison, WisconsinUniversity of Wisconsin-Madison
Dec 5, 2022
Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia Trial in Maitland, Spokane (BIIB080,
Recruiting
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Alzheimer's Disease Dementia
- BIIB080
- BIIB080-matching placebo
-
Lady Lake, Florida
- +5 more
Jan 20, 2023
The Swedish BioFINDER - Preclinical AD Study
Recruiting
- Alzheimer Disease
- +2 more
- Plasma tau
- +4 more
-
Malmö, SwedenSkåne University Hospital
Nov 8, 2023
Alzheimer's Disease (AD), Lewy Body Dementia (LBD), Frontotemporal Degeneration (FTD) Trial in Paris (REALSOCOG, BCS,
Not yet recruiting
- Alzheimer's Disease (AD)
- +2 more
- REALSOCOG
- +2 more
-
Paris, FranceHôpital de la Pitié-Salpêtrière
Oct 3, 2022
Alzheimer (AD) Trial in New Haven ([18F]GTP1, [18F]PI-2620, [18F]MK-6240)
Recruiting
- Alzheimer Disease (AD)
- [18F]GTP1
- +2 more
-
New Haven, ConnecticutInvicro, a Konica Minolta company
Aug 2, 2022